GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (XCNQ:MOOD) » Definitions » EV-to-EBITDA

Doseology Sciences (XCNQ:MOOD) EV-to-EBITDA : -0.39 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Doseology Sciences EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Doseology Sciences's enterprise value is C$0.52 Mil. Doseology Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.32 Mil. Therefore, Doseology Sciences's EV-to-EBITDA for today is -0.39.

The historical rank and industry rank for Doseology Sciences's EV-to-EBITDA or its related term are showing as below:

XCNQ:MOOD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1.22   Med: -0.32   Max: 0.5
Current: -0.39

During the past 4 years, the highest EV-to-EBITDA of Doseology Sciences was 0.50. The lowest was -1.22. And the median was -0.32.

XCNQ:MOOD's EV-to-EBITDA is ranked worse than
100% of 451 companies
in the Biotechnology industry
Industry Median: 9.67 vs XCNQ:MOOD: -0.39

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Doseology Sciences's stock price is C$0.37. Doseology Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.271. Therefore, Doseology Sciences's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Doseology Sciences EV-to-EBITDA Historical Data

The historical data trend for Doseology Sciences's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences EV-to-EBITDA Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23
EV-to-EBITDA
- - -0.90 0.01

Doseology Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.67 0.01 -0.59 0.34

Competitive Comparison of Doseology Sciences's EV-to-EBITDA

For the Biotechnology subindustry, Doseology Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doseology Sciences's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's EV-to-EBITDA falls into.



Doseology Sciences EV-to-EBITDA Calculation

Doseology Sciences's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.517/-1.323
=-0.39

Doseology Sciences's current Enterprise Value is C$0.52 Mil.
Doseology Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doseology Sciences  (XCNQ:MOOD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Doseology Sciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.37/-0.271
=At Loss

Doseology Sciences's share price for today is C$0.37.
Doseology Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.271.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Doseology Sciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Doseology Sciences (XCNQ:MOOD) Business Description

Traded in Other Exchanges
Address
116 - 5100 Anderson Way, Unit 197, Vernon, BC, CAN, V1T 0C4
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the aim of making a meaningful impact on the mental health pandemic and improving overall health.

Doseology Sciences (XCNQ:MOOD) Headlines

No Headlines